Ruth A. Keri
Affiliations: | Pharmacology | Case Western Reserve University, Cleveland Heights, OH, United States |
Area:
Pharmacology, Oncology, Cell BiologyGoogle:
"Ruth Keri"Children
Sign in to add traineeErin L. Milliken | grad student | 2005 | Case Western |
Melissa D. Landis | grad student | 2006 | Case Western |
Gina M. Gernardo | grad student | 2011 | Case Western |
Jennifer L. Yori | grad student | 2011 | Case Western |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Caputo A, Vipparthi K, Bazeley P, et al. (2023) Spatial transcriptomics suggests that alterations occur in the preneoplastic breast microenvironment of BRCA1/2 mutation carriers. Molecular Cancer Research : McR |
Kao HY, Pai CP, Wang H, et al. (2023) The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer. Research Square |
Bobbitt JR, Seachrist D, Keri RA. (2023) Chromatin organization and transcriptional programming of breast cancer cell identity. Endocrinology |
Caputo A, Vipparthi K, Bazeley P, et al. (2023) Alterations in the preneoplastic breast microenvironment of mutation carriers revealed by spatial transcriptomics. Biorxiv : the Preprint Server For Biology |
Anstine LJ, Majmudar PR, Aponte A, et al. (2023) TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis. Cancer Research |
Cuellar-Vite L, Weber-Bonk KL, Abdul-Karim FW, et al. (2022) Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy. Cancers. 14 |
Seachrist DD, Anstine LJ, Keri RA. (2021) FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer. Cancers. 13 |
Piemonte KM, Anstine LJ, Keri RA. (2021) Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer. Endocrinology. 162 |
Webb BM, Bryson BL, Williams-Medina E, et al. (2021) TGF-β/Activin Signaling Promotes CDK7 Inhibitor Resistance in Triple Negative Breast Cancer Cells through Upregulation of Multidrug Transporters. The Journal of Biological Chemistry. 101162 |
Adorno-Cruz V, Hoffmann AD, Liu X, et al. (2021) promotes expression of and in enhancing breast cancer stemness and metastasis. Genes & Diseases. 8: 493-508 |